KATHLEEN DEVEJIAN: Open Payments
NPI 1528579257 · HAMPSTEAD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 39 payments from 14 companies in 2025. Trend: 2023 $416 · 2024 $1,661 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $281 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Exact Sciences Corporation | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Amgen Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: AIRSUPRA, UBRELVY, QULIPTA, VRAYLAR, Auvelity, The Cologuard Plus Collection Kit, CAPLYTA, ROTATEQ.
Industry payments across NH — which companies pay providers there.
